Provided by Tiger Trade Technology Pte. Ltd.

WAVE Life Sciences

5.29
+0.04000.76%
Pre-market: 5.350.0600+1.13%08:55 EDT
Volume:2.72M
Turnover:14.51M
Market Cap:1.04B
PE:-4.91
High:5.48
Open:5.30
Low:5.27
Close:5.25
52wk High:21.73
52wk Low:5.01
Shares:197.00M
Float Shares:94.77M
Volume Ratio:0.90
T/O Rate:2.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0766
EPS(LYR):-1.2118
ROE:-67.42%
ROA:-33.60%
PB:2.30
PE(LYR):-4.37

Loading ...

Wave Life Sciences price target raised to $35 from $33 at Wedbush

TIPRANKS
·
Mar 06

Wave Life Sciences to present late-breaking WVE-006 RestorAATion-2 data at ATS International Conference

Reuters
·
Mar 05

Wave Life Sciences Obesity Proof Of Concept Sparks Focus On Pipeline Upside

Simply Wall St.
·
Mar 04

Wave Life Sciences Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 02

Wave Life Sciences SVP Chris Francis Disposes of Common Shares

Reuters
·
Feb 28

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Kymera Therapeutics (KYMR)

TIPRANKS
·
Feb 28

Stock Track | WAVE Life Sciences Plummets 5.03% Intraday Following Analyst Ratings Release

Stock Track
·
Feb 27

Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Progyny (PGNY) and Wave Life Sciences (WVE)

TIPRANKS
·
Feb 27

Stock Track | WAVE Life Sciences Soars 5.06% Intraday on Q4 Revenue Beat and Promising Pipeline Updates

Stock Track
·
Feb 27

WAVE Life Sciences Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

Wave Life Sciences Q4 revenue beats analyst expectations

Reuters
·
Feb 26

Earnings Flash (WVE) Wave Life Sciences Posts Q4 Loss $0.30 a Share, vs. FactSet Est of $0.26 Loss

MT Newswires Live
·
Feb 26

WAVE Life Sciences Q4 2025 EPS $(0.30) Misses $(0.27) Estimate, Sales $17.244M Beat $16.547M Estimate

Benzinga Earnings
·
Feb 26

Wave (WVE) Q4 revenue USD 17.2 million (-79.4%)

Reuters
·
Feb 26

Wave Life Sciences Q4 Net Income USD -53.179 Million VS. Ibes Estimate USD -45.9 Million

THOMSON REUTERS
·
Feb 26

Wave Life Sciences Q4 Pretax Profit USD -53.179 Million VS. Ibes Estimate USD -45.7 Million

THOMSON REUTERS
·
Feb 26

Wave Life Sciences Q4 EPS USD -0.3

THOMSON REUTERS
·
Feb 26

Wave Life Sciences Ltd: Well Capitalized With Cash and Cash Equivalents of $602.1 Mln as of December 31, 2025 and Expected Cash Runway Into 3Q 2028

THOMSON REUTERS
·
Feb 26